Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated with prior immunotherapy.

Last Saturday's stealth B-2 bomber's strikes on Iran's nuclear program were a clear and decisive win for the United States despite a dubious leaked 'LOW CONFIDENCE' preliminary Defense ...

Maybe life would be a little bit better if everything didn’t have to be so lifelike.

After getting completely obliterated by the United States and Israel, Iran has hilariously declared victory.

Trump administration's 'Operation Midnight Hammer' hit Iran's nuclear program so effectively with B-2 stealth bombers that even former President Jimmy Carter would have likely swung that hammer.

The MHRA has approved serplulimab, the UK’s first anti-PD-1 antibody for extensive-stage small cell lung cancer, improving survival options for adults.